Longboard Pharmaceuticals, Inc. (LBPH)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch LBPH
See up to 3 months of LBPH. The 7-day demo opens the 1M and 3M ranges and puts LBPH on your watchlist.
Start 7-day demoLatest LBPH insider trades
About Longboard Pharmaceuticals, Inc. (LBPH)
The SEC lists Longboard Pharmaceuticals, Inc. under CIK 0001832168, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
LBPH Form 4 activity by transaction type, last 90 days
No Form 4 activity for LBPH in the last 90 days.
LBPH insider transactions (Form 4)
5214 Form 4 filings on record, the earliest from Oct 16, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Goff Corinne le | Derivative | Employee Stock Option (right to buy) | 12,367 | - | - | |
| Goff Corinne le | Derivative | Employee Stock Option (right to buy) | 13,397 | - | - | |
| Goff Corinne le | Derivative | Employee Stock Option (right to buy) | 12,367 | - | - | |
| Goff Corinne le | Derivative | Employee Stock Option (right to buy) | 12,500 | - | - | |
| Goff Corinne le | Derivative | Employee Stock Option (right to buy) | 22,500 | - | - | |
 Casey Lynch | Derivative | Employee Stock Option (right to buy) | 12,367 | - | - | |
| Casey Lynch | Derivative | Employee Stock Option (right to buy) | 14,428 | - | - | |
| Casey Lynch | Derivative | Employee Stock Option (right to buy) | 12,367 | - | - | |
| Casey Lynch | Derivative | Employee Stock Option (right to buy) | 12,500 | - | - | |
| Casey Lynch | Derivative | Employee Stock Option (right to buy) | 22,500 | - | - | |
| Kevin Robert Lind - Officer | Other | Common Stock | 363,740 | $60.00 | $21.82M | |
| Kevin Robert Lind - Officer | Derivative | Employee Stock Option (right to buy) | 255,377 | - | - | |
| Kevin Robert Lind - Officer | Derivative | Employee Stock Option (right to buy) | 192,783 | - | - | |
| Kevin Robert Lind - Officer | Derivative | Employee Stock Option (right to buy) | 325,850 | - | - | |
| Kevin Robert Lind - Officer | Derivative | Employee Stock Option (right to buy) | 332,134 | - | - | |
| Kevin Robert Lind - Officer | Derivative | Restricted Stock Unit | 22,000 | - | - | |
| Vincent Aurentz | Derivative | Employee Stock Option (right to buy) | 12,367 | - | - | |
| Vincent Aurentz | Derivative | Employee Stock Option (right to buy) | 7,214 | - | - | |
| Vincent Aurentz | Derivative | Employee Stock Option (right to buy) | 12,367 | - | - | |
| Vincent Aurentz | Derivative | Employee Stock Option (right to buy) | 12,500 | - | - | |
| Vincent Aurentz | Derivative | Employee Stock Option (right to buy) | 22,500 | - | - | |
| Brandi Roberts - Officer | Derivative | Employee Stock Option (right to buy) | 139,380 | - | - | |
| Brandi Roberts - Officer | Derivative | Employee Stock Option (right to buy) | 90,000 | - | - | |
| Brandi Roberts - Officer | Derivative | Employee Stock Option (right to buy) | 119,700 | - | - | |
| Brandi Roberts - Officer | Derivative | Employee Stock Option (right to buy) | 90,580 | - | - | |
| Brandi Roberts - Officer | Derivative | Restricted Stock Unit | 15,090 | - | - | |
| Brandi Roberts - Officer | Derivative | Restricted Stock Unit | 7,900 | - | - | |
| Randall Kaye - Officer | Other | Common Stock | 30,554 | $60.00 | $1.83M | |
| Randall Kaye - Officer | Derivative | Employee Stock Option (right to buy) | 175,946 | - | - | |
| Randall Kaye - Officer | Derivative | Employee Stock Option (right to buy) | 96,300 | - | - | |
| Randall Kaye - Officer | Derivative | Employee Stock Option (right to buy) | 107,560 | - | - | |
| Randall Kaye - Officer | Derivative | Restricted Stock Unit | 17,920 | - | - | |
| Randall Kaye - Officer | Derivative | Restricted Stock Unit | 9,500 | - | - | |
| Paul J. Sekhri | Derivative | Employee Stock Option (right to buy) | 25,461 | - | - | |
| Paul J. Sekhri | Derivative | Employee Stock Option (right to buy) | 12,367 | - | - | |
| Paul J. Sekhri | Derivative | Employee Stock Option (right to buy) | 12,500 | - | - | |
| Paul J. Sekhri | Derivative | Employee Stock Option (right to buy) | 22,500 | - | - | |
| Phillip M. Schneider | Derivative | Employee Stock Option (right to buy) | 25,461 | - | - | |
| Phillip M. Schneider | Derivative | Employee Stock Option (right to buy) | 12,367 | - | - | |
| Phillip M. Schneider | Derivative | Employee Stock Option (right to buy) | 12,500 | - | - | |
| Phillip M. Schneider | Derivative | Employee Stock Option (right to buy) | 22,500 | - | - | |
| Randall Kaye - Officer | Option exercise | Common Stock | 30,554 | $6.00 | $183K | |
| Randall Kaye - Officer | Option exercise | Stock Option (Right to Buy) | 30,554 | $0.00 | - | |
| Kevin Robert Lind - Officer | Option exercise | Common Stock | 12,808 | $3.12 | $40K | |
| Kevin Robert Lind - Officer | Gift | Common Stock | 80,000 | $0.00 | - | |
| Kevin Robert Lind - Officer | Option exercise | Stock Option (Right to Buy) | 12,808 | $0.00 | - | |
| Kevin Robert Lind - Officer | Grant or award | Retention Restricted Stock Units | 22,000 | $0.00 | - | |
| Brandi Roberts - Officer | Grant or award | Retention Restricted Stock Units | 7,900 | $0.00 | - | |
| Randall Kaye - Officer | Grant or award | Retention Restricted Stock Units | 9,500 | $0.00 | - | |
| Randall Kaye - Officer | Option exercise | Common Stock | 16,667 | $4.35 | $73K | |
| Randall Kaye - Officer | Open-market sale | Common Stock | 16,667 | $59.04 | $984K | |
| Randall Kaye - Officer | Option exercise | Stock Option (Right to Buy) | 16,667 | $0.00 | - |
LBPH insider trading FAQ
What is the latest insider trade for LBPH?
Longboard Pharmaceuticals, Inc. (LBPH) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-12-02. The full record for LBPH runs to 14 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LBPH stock?
No insider purchases of LBPH were filed in the last 90 days.
How many insiders are selling LBPH stock?
No insider sales of LBPH were filed in the last 90 days. 1 sale is on record for this company.
Where can I see LBPH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LBPH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Goff Corinne le view on EDGAR
- - Casey Lynch view on EDGAR
- - Kevin Robert Lind view on EDGAR
- - Vincent Aurentz view on EDGAR
- - Brandi Roberts view on EDGAR
- - Randall Kaye view on EDGAR
- - Paul J. Sekhri view on EDGAR
- - Phillip M. Schneider view on EDGAR
- - Randall Kaye
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where LBPH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LBPH with a 7-day demo
- LBPH on your watchlist
- Every LBPH Form 4 filing on record
- Up to 3 months of LBPH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
